{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T02:36:15Z","timestamp":1782700575451,"version":"3.54.5"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.blre.2021.100867","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T23:49:03Z","timestamp":1626479343000},"page":"100867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Antibiotics to modify sickle cell disease vaso-occlusive crisis?"],"prefix":"10.1016","volume":"50","author":[{"given":"Connor","family":"Stewart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Poplawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ogechukwu","family":"Egini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dibyendu","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seah H.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2021.100867_bb0005","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0140-6736(12)61229-X","article-title":"Global epidemiology of sickle haemoglobin in neonates: a contemporary geostatistical model-based map and population estimates","volume":"381","author":"Piel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.blre.2021.100867_bb0010","author":"Centers for Disease Control and Prevention, (CDC)"},{"key":"10.1016\/j.blre.2021.100867_bb0015","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/ajh.25724","article-title":"Treating sickle cell anemia: a new era dawns","volume":"95","author":"Steinberg","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0020","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1056\/NEJMoa1903212","article-title":"A phase 3 randomized trial of voxelotor in sickle cell disease","volume":"381","author":"Vichinsky","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2021.100867_bb0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJMoa1611770","article-title":"Crizanlizumab for the prevention of pain crises in sickle cell disease","volume":"376","author":"Ataga","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2021.100867_bb0030","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1715971","article-title":"A phase 3 trial of l-glutamine in sickle cell disease","volume":"379","author":"Niihara","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2021.100867_bb0035","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.hemonc.2017.05.008","article-title":"Hematopoietic stem cell transplantation for sickle cell disease: the changing landscape","volume":"10","author":"Kassim","year":"2017","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"10.1016\/j.blre.2021.100867_bb0040","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1056\/NEJMoa1609677","article-title":"Gene therapy in a patient with sickle cell disease","volume":"376","author":"Ribeil","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2021.100867_bb0045","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMoa2031054","article-title":"CRISPR-Cas9 gene editing for sickle cell disease and \u03b2-thalassemia","volume":"384","author":"Frangoul","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2021.100867_bb0050","author":"Centers for Disease Control and Prevention (CDC)"},{"key":"10.1016\/j.blre.2021.100867_bb0055","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bcmd.2015.03.012","article-title":"The effects of hydroxyurea and bone marrow transplant on anti-m\u00fcllerian hormone (AMH) levels in females with sickle cell anemia","volume":"55","author":"Elchuri","year":"2015","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.blre.2021.100867_bb0060","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1001\/archpedi.1994.02170080026005","article-title":"Reference values and hematologic changes from birth to 5 years in patients with sickle cell disease","volume":"148","author":"Brown","year":"1994","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.blre.2021.100867_bb0065","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1093\/ajcp\/79.6.667","article-title":"Relationship red blood cell morphology in sickle cell anemia as determined by image processing analysis: the relationship to painful crises","volume":"79","author":"Westerman","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.blre.2021.100867_bb0070","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.3324\/haematol.2013.088021","article-title":"Nucleosomes and neutrophil activation in sickle cell disease painful crisis","volume":"98","author":"Schimmel","year":"2013","journal-title":"Haematologica."},{"key":"10.1016\/j.blre.2021.100867_bb0075","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1002\/rth2.12463","article-title":"Neutrophil extracellular trap regulators in sickle cell disease: modulation of gene expression of PADI4, neutrophil elastase, and myeloperoxidase during vaso-occlusive crisis","volume":"5","author":"Hounkpe","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.blre.2021.100867_bb0080","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1073\/pnas.052522799","article-title":"Primary role for adherent leukocytes in sickle cell vascular occlusion: a new paradigm","volume":"99","author":"Turhan","year":"2002","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.blre.2021.100867_bb0085","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/bjh.16273","article-title":"Intestinal pathophysiological and microbial changes in sickle cell disease: potential targets for therapeutic intervention","volume":"188","author":"Dutta","year":"2020","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2021.100867_bb0090","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/ajh.20819","article-title":"Adherent leukocytes capture sickle erythrocytes in an in vitro flow model of vaso-occlusion","volume":"82","author":"Finnegan","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0095","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1542\/peds.103.3.640","article-title":"Silent cerebral infarcts in sickle cell anemia: a risk factor analysis","volume":"103","author":"Kinney","year":"1999","journal-title":"Pediatr."},{"key":"10.1016\/j.blre.2021.100867_bb0100","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1182\/blood.V84.2.643.643","article-title":"The acute chest syndrome in sickle cell disease: incidence and risk factors. The cooperative study of sickle cell disease","volume":"84","author":"Castro","year":"1994","journal-title":"Blood."},{"key":"10.1016\/j.blre.2021.100867_bb0105","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease-life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2021.100867_bb0110","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005792-199611000-00002","article-title":"Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive\u201c switching\u201d agent. The multicenter study of hydroxyurea in sickle cell anemia","volume":"75","author":"Charache","year":"1996","journal-title":"Medicine."},{"key":"10.1016\/j.blre.2021.100867_bb0115","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jlb.66.3.411","article-title":"Neutrophil activation in sickle cell disease","volume":"66","author":"Lard","year":"1991","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.blre.2021.100867_bb0120","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/ajh.20059","article-title":"Inflammatory potential of neutrophils detected in sickle cell disease","volume":"76","author":"Lum","year":"2004","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0125","doi-asserted-by":"crossref","first-page":"E634","DOI":"10.1002\/ajh.24868","article-title":"Inflammatory and endothelial markers during vaso-occlusive crisis and acute chest syndrome in sickle cell disease","volume":"92","author":"Schimmel","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0130","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1182\/blood.V99.11.4160","article-title":"Neutrophil activation by heme: implications for inflammatory processes","volume":"99","author":"Gra\u00e7a-Souza","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.blre.2021.100867_bb0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12967-019-1938-8","article-title":"Intestinal injury and gut permeability in sickle cell disease","volume":"17","author":"Dutta","year":"2019","journal-title":"J Transl Med"},{"key":"10.1016\/j.blre.2021.100867_bb0140","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nature15367","article-title":"Neutrophil ageing is regulated by the microbiome","volume":"525","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.blre.2021.100867_bb0145","doi-asserted-by":"crossref","first-page":"27949","DOI":"10.1074\/jbc.M504049200","article-title":"Innate immune defense of the sponge Suberites domuncula against bacteria involves a MyD88-dependent signaling pathway: induction of a perforin-like molecule","volume":"280","author":"Wiens","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.blre.2021.100867_bb0150","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/08830185.2016.1261318","article-title":"Pathogen recognition and toll-like receptor targeted therapeutics in innate immune cells","volume":"36","author":"Tartey","year":"2017","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.blre.2021.100867_bb0155","doi-asserted-by":"crossref","first-page":"8659","DOI":"10.1038\/s41598-019-45270-4","article-title":"Depletion of intestinal microbiome partially rescues bone loss in sickle cell disease male mice","volume":"9","author":"Tavakoli","year":"2019","journal-title":"Sci Report"},{"key":"10.1016\/j.blre.2021.100867_bb0160","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200065","article-title":"Nociceptors protect sickle cell disease mice from vaso-occlusive episodes and chronic organ damage","volume":"218","author":"Xu","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.blre.2021.100867_bb0165","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3389\/fmicb.2017.00272","article-title":"Anti-obesity effect of capsaicin in mice fed with high-fat diet is associated with an increase in population of the gut bacterium Akkermansia muciniphila","volume":"8","author":"Shen","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.blre.2021.100867_bb0170","first-page":"470","article-title":"Gut microbiota mediates the protective effects of dietary capsaicin against chronic low-grade inflammation and associated obesity induced by high-fat diet","volume":"8","author":"Kang","year":"2017","journal-title":"MBio."},{"key":"10.1016\/j.blre.2021.100867_bb0175","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1038\/s41591-019-0495-2","article-title":"Supplementation with Akkermansia muciniphila in overweight and obese human volunteers: a proof-of-concept exploratory study","volume":"25","author":"Depommier","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.blre.2021.100867_bb0180","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1002\/ajh.25456","article-title":"Elevated urinary 3-indoxyl sulfate in sickle cell disease","volume":"94","author":"Dutta","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0185","doi-asserted-by":"crossref","first-page":"S631","DOI":"10.1016\/S0016-5085(17)32237-0","article-title":"Gut microbiome analysis reveals major dysbiosis in sickle cell diseases patients with a prevalence of Veillonella strains","volume":"152","author":"Brim","year":"2017","journal-title":"Gastroenterol."},{"key":"10.1016\/j.blre.2021.100867_bb0190","doi-asserted-by":"crossref","first-page":"E91","DOI":"10.1002\/ajh.25019","article-title":"Intestinal microbiome analysis revealed dysbiosis in sickle cell disease","volume":"93","author":"Lim","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0195","doi-asserted-by":"crossref","first-page":"583446","DOI":"10.3389\/fped.2020.583446","article-title":"Differences in gut microbiome in hospitalized immunocompetent vs. immunocompromised children, including those with sickle cell disease","volume":"8","author":"Mohandas","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/j.blre.2021.100867_bb0200","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S0039-6060(03)00302-7","article-title":"Enterocyte apoptosis and barrier function are modulated by SIgA after exposure to bacteria and hypoxia\/reoxygenation","volume":"134","author":"Diebel","year":"2003","journal-title":"Surg."},{"key":"10.1016\/j.blre.2021.100867_bb0205","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12967-016-1092-5","article-title":"Sickle cell vaso-occlusive crisis: It\u2019s a gut feeling","volume":"14","author":"Lim","year":"2016","journal-title":"J Transl Med"},{"key":"10.1016\/j.blre.2021.100867_bb0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1186\/s12967-018-1622-4","article-title":"Invasive non-typhoidal Salmonella in sickle cell disease in Africa: is increased gut permeability the missing link?","volume":"16","author":"Lim","year":"2018","journal-title":"J Transl Med"},{"key":"10.1016\/j.blre.2021.100867_bb0215","doi-asserted-by":"crossref","DOI":"10.1111\/joim.13238","article-title":"Antimicrobial therapy during cancer treatment: beyond antibacterial effects","author":"Ghanem","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.blre.2021.100867_bb0220","doi-asserted-by":"crossref","DOI":"10.1111\/bjh.17439","article-title":"Antibiotic use in adults during sickle cell vaso-occlusive crisis: is it time for a controlled trial?","author":"Jang","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2021.100867_bb0225","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/joim.13173","article-title":"A contemporary review of clostridioides difficile infections in patients with haematologic diseases","volume":"289","author":"Dutta","year":"2021","journal-title":"J Intern Med"},{"key":"10.1016\/j.blre.2021.100867_bb0230","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/2040622313496126","article-title":"Gastrointestinal bacterial overgrowth: pathogenesis and clinical significance","volume":"4","author":"Sachdev","year":"2013","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/j.blre.2021.100867_bb0235","doi-asserted-by":"crossref","first-page":"382","DOI":"10.4161\/gmic.25723","article-title":"Cirrhosis, bile acids and gut microbiota: unraveling a complex relationship","volume":"4","author":"Ridlon","year":"2013","journal-title":"Gut Microbes"},{"key":"10.1016\/j.blre.2021.100867_bb0240","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cell.2009.09.033","article-title":"Induction of intestinal Th17 cells by segmented filamentous bacteria","volume":"139","author":"Ivanov","year":"2009","journal-title":"Cell."},{"key":"10.1016\/j.blre.2021.100867_bb0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.immuni.2020.06.025","article-title":"The gut microbiome regulates psychological-stress-induced inflammation","volume":"53","author":"Xu","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.blre.2021.100867_bb0250","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJMc1815711","article-title":"Low incidence of hospital-onset Clostridium difficile infection in sickle cell disease","volume":"380","author":"Ahmed","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2021.100867_bb0255","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2019.244582","article-title":"Very low incidence of Clostridioides difficile infection in pediatric sickle cell disease patients","author":"Lee","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2021.100867_bb0260","doi-asserted-by":"crossref","first-page":"E325","DOI":"10.1002\/ajh.25637","article-title":"Rifaximin for sickle cell disease","volume":"94","author":"Lim","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0265","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.cgh.2013.12.021","article-title":"Rifaximin is safe and well tolerated for long-term maintenance of remission from overt hepatic encephalopathy","volume":"12","author":"Mullen","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.blre.2021.100867_bb0270","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.13434","article-title":"Review article: the antimicrobial effects of rifaximin on the gut microbiota","volume":"43","author":"DuPont","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.blre.2021.100867_bb0275","doi-asserted-by":"crossref","first-page":"E83","DOI":"10.1002\/ajh.25722","article-title":"Rifaximin on intestinally-related pathologic changes in sickle cell disease","volume":"95","author":"Dutta","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0280","doi-asserted-by":"crossref","first-page":"E151","DOI":"10.1002\/ajh.25798","article-title":"Clinicopathologic consequences following discontinuation of rifaximin in patients with sickle cell disease","volume":"95","author":"Lim","year":"2020","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0285","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/19490976.2018.1502536","article-title":"Assessment of urinary 3-indoxyl sulfate as a marker for gut microbiota diversity and abundance of clostridiales","volume":"10","author":"Farowski","year":"2019","journal-title":"Gut Microbes"},{"key":"10.1016\/j.blre.2021.100867_bb0290","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.3748\/wjg.v23.i25.4491","article-title":"Eubiotic properties of rifaximin: disruption of the traditional concepts in gut microbiota modulation","volume":"23","author":"Ponziani","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.blre.2021.100867_bb0295","doi-asserted-by":"crossref","first-page":"E175","DOI":"10.1002\/ajh.25467","article-title":"Effects of rifaximin on circulating aged neutrophils in sickle cell disease","volume":"94","author":"Dutta","year":"2019","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0300","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3389\/fcimb.2019.00044","article-title":"Rifaximin alters intestinal microbiota and prevents progression of ankylosing spondylitis in mice","volume":"9","author":"Yang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.blre.2021.100867_bb0305","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.ejphar.2011.06.058","article-title":"Inhibition of NF-kappaB by a PXR-dependent pathway mediates counter-regulatory activities of rifaximin on innate immunity in intestinal epithelial cells","volume":"668","author":"Mencarelli","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.blre.2021.100867_bb0310","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/135910530000500109","article-title":"The role of stress and mood in sickle cell disease pain: an analysis of daily diary data","volume":"5","author":"Porter","year":"2000","journal-title":"J Health Psychol"},{"key":"10.1016\/j.blre.2021.100867_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-244X-14-207","article-title":"Sleep disturbance, depression and pain in adults with sickle cell disease","volume":"14","author":"Wallen","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.blre.2021.100867_bb0320","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/MPH.0b013e3181d869d5","article-title":"Depression, anxiety, and stress comorbidities in sickle cell anemia patients with vaso-occlusive crisis","volume":"32","author":"Mahdi","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2021.100867_bb0325","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043232","article-title":"Effects of psychological stress on innate immunity and metabolism in humans: a systematic analysis","volume":"7","author":"Priyadarshini","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.blre.2021.100867_bb0330","doi-asserted-by":"crossref","first-page":"219","DOI":"10.5664\/jcsm.4530","article-title":"Sleep disorders in adult sickle cell patients","volume":"11","author":"Sharma","year":"2015","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/j.blre.2021.100867_bb0335","first-page":"755","article-title":"Sleep-disordered breathing in patients with sickle cell disease","volume":"97","author":"Raghunathan","year":"2018","journal-title":"Ann Hematol"},{"key":"10.1016\/j.blre.2021.100867_bb0340","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2011.028","article-title":"The role of infection in the pathogenesis of vaso-occlusive crisis in patients with sickle cell disease","volume":"3","author":"Ahmed","year":"2011","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.blre.2021.100867_bb0345","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2014.018","article-title":"Procalcitonin as a biomarker of bacterial infection in sickle cell vaso-occlusive crisis","volume":"6","author":"Patel","year":"2014","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.blre.2021.100867_bb0350","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1056\/NEJM200006223422502","article-title":"Causes and outcomes of the acute chest syndrome in sickle cell disease","volume":"342","author":"Vichinsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2021.100867_bb0355","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/1060028019846118","article-title":"Antibiotic use and respiratory pathogens in adults with sickle cell disease and acute chest syndrome","volume":"53","author":"Claudio","year":"2019","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.blre.2021.100867_bb0360","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/MPH.0b013e3182495573","article-title":"Procalcitonin is more useful than C-reactive protein in differentiation of fever in patients with sickle cell disease","volume":"34","author":"Unal","year":"2012","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.blre.2021.100867_bb0365","doi-asserted-by":"crossref","first-page":"153","DOI":"10.7326\/M18-3640","article-title":"Excess antibiotic treatment duration and adverse events in patients hospitalized with pneumonia: a multihospital cohort study","volume":"171","author":"Vaughn","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2021.100867_bb0370","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1111\/gtc.12649","article-title":"Oral administration of antibiotics results in fecal occult bleeding due to metabolic disorders and defective proliferation of the gut epithelial cell in mice","volume":"23","author":"Sonoda","year":"2018","journal-title":"Genes Cells"},{"key":"10.1016\/j.blre.2021.100867_bb0375","doi-asserted-by":"crossref","first-page":"G591","DOI":"10.1152\/ajpgi.1995.269.4.G591","article-title":"L-glutamine and L-asparagine stimulate ODC activity and proliferation in a porcine jejunal enterocyte line","volume":"269","author":"Kandil","year":"1995","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.blre.2021.100867_bb0380","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X21000734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X21000734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T20:26:40Z","timestamp":1759436800000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X21000734"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":76,"alternative-id":["S0268960X21000734"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2021.100867","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotics to modify sickle cell disease vaso-occlusive crisis?","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2021.100867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100867"}}